289
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editors

Higher incidence of hip fracture in newly diagnosed schizophrenic patients in Taiwan

Article: 20911 | Published online: 18 Apr 2013

Hip fracture is a major public health concern due to its poor outcome and serious socioeconomic burden in older people (Citation1). Evidence has shown that many factors are related to increased risk of hip fracture, but psychiatric diseases are not confirmatory (Citation2, Citation3). A case-control study by Howard et al. in the United Kingdom has shown that schizophrenia is associated with increased risk of hip fracture in univariate analysis (odds ratio [OR]=1.73, 95% CI=1.32–2.28), but association is no longer found in multivariate analysis (Citation3). To date, no clinical study has focused on the relationship between schizophrenia and the risk of hip fracture in older people in Taiwan. In order to clarify this issue, we used the database from the Taiwan National Health Insurance program to conduct this population-based cohort study. The details of the insurance program can be found in previous studies (Citation4Citation6).

In this study, we randomly selected 445 subjects aged 65 years or older with newly diagnosed schizophrenia as the case group based on the diagnosis codes of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9 codes 295 and V11.0, 210 men and 235 women, mean age [standard deviation]=75.2 [6.9] years) and 1,780 subjects aged 65 years or older without schizophrenia as the comparison group (840 men and 940 women, mean age [standard deviation]=74.2 [7.1] years), from 2000 to 2010. Both groups were matched for gender, age and year of diagnosis. We measured the incidence of hip fracture (ICD-9 codes 820) until either hip fracture was diagnosed or until 31 December 2010. To reduce the biased results, subjects with hip fracture diagnosed before entering this cohort were excluded.

The schizophrenia group had a significantly higher incidence of hip fracture than did the non-schizophrenia group (20.3 vs. 10.6 per 1,000 person-years, incidence rate ratio [IRR]=1.91, 95% CI=1.49–2.44). The subanalysis stratified by gender and age group also displayed that the incidence rates of hip fracture were all higher in the schizophrenia group than that in the non-schizophrenia group, with statistical significance. Men with schizophrenia had a higher risk of hip fracture than did women with schizophrenia (IRR 3.26 vs. 1.42). Subjects with schizophrenia aged 75–84 had the highest incidence than other subgroups (incidence rate=35.4 per 1,000 person-years), but subjects with schizophrenia aged 65–74 had a higher risk of hip fracture (IRR=2.14, 95% CI=1.51–3.02). The risk of hip fracture was higher among subjects with a duration of diagnosing schizophrenia of less than 2 years (IRR=2.82, 95% CI=2.16–3.69), as compared to those with a duration ≥2 years (IRR=1.54, 95% CI=1.14–2.07) ().

Table 1. Incidence rates of hip fracture for schizophrenia group and non-schizophrenia group

A case-control study by Bolton et al. in Canada has shown that schizophrenia is associated with increased risk of osteoporotic fractures after being adjusted for covariates (OR=1.61, 95% CI=1.27–2.04) but not focusing on hip fracture (Citation7). In this study, patients with schizophrenia have a 1.9-fold increased risk of hip fracture. In further analysis, we also found that the risk of hip fracture is 2.8-fold in patients with duration of less than 2 years after diagnosing schizophrenia, as compared to subjects without schizophrenia. This means that more efforts should be made to prevent falls in older people with schizophrenia, particularly in the first 2 years of diagnosis. Due to inconsistent results from the aforementioned studies, additional studies are needed to determine the relationship between schizophrenia and hip fracture incidence in older people.

Shih-Wei Lai
School of Medicine
China Medical University
Taichung, Taiwan
Department of Family Medicine
China Medical University Hospital
Taichung, Taiwan

Cheng-Li Lin
Department of Public Health
China Medical University
Taichung, Taiwan
Management Office for Health Data
China Medical University Hospital
Taichung, Taiwan
Kuan-Fu Liao
Graduate Institute of Integrated Medicine
China Medical University
Taichung, Taiwan
Department of Internal Medicine
Taichung Tzu Chi General Hospital
Taichung, Taiwan
Department of Health Care Administration
Central Taiwan University of Science and Technology
Taichung, Taiwan
E-mail: [email protected]

Conflict of interest and funding

The authors disclose no conflicts of interest. This study was supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funding agency did not influence the study design, data collection and analysis, decision to publish or preparation of the manuscript.

References

  • Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep. 2003; 1: 78–85.
  • Beer C, Giles E. Hip fracture – challenges in prevention and management. Aust Fam Physician. 2005; 34: 673–6.
  • Howard L, Kirkwood G, Leese M. Risk of hip fracture in patients with a history of schizophrenia. Br J Psychiatry. 2007; 190: 129–34.
  • Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore). 2010; 89: 295–9.
  • Lai SW, Su LT, Lin CH, Tsai CH, Sung FC, Hsieh DP. Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: a population-based study. Psychogeriatrics. 2011; 11: 150–6.
  • Lai SW, Lin CH, Liao KF, Su LT, Sung FC, Lin CC. Association between polypharmacy and dementia in older people: a population-based case-control study in Taiwan. Geriatr Gerontol Int. 2012; 12: 491–8.
  • Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD. Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol. 2008; 28: 384–91.